Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Influenza Vaccine Effectiveness Against Influenza A–Associated Emergency Department, Urgent Care, and Hospitalization Encounters Among US Adults, 2022–2023
Mark W. Tenforde, Zachary A. Weber, Duck‐Hye Yang, et al.
The Journal of Infectious Diseases (2023) Vol. 230, Iss. 1, pp. 141-151
Open Access | Times Cited: 12

Showing 12 citing articles:

Winter viruses: we can do more to prevent a surge in cases
Lindsay Broadbent
BMJ (2025), pp. r77-r77
Closed Access | Times Cited: 1
Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network
Angela Rose, Francisco Pozo, Iván Martínez‐Baz, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 2
Open Access | Times Cited: 10
Evidence base for yearly respiratory virus vaccines: Current status and proposed improved strategies
Mariana Barosa, John P. A. Ioannidis, Vinay Prasad
European Journal of Clinical Investigation (2024) Vol. 54, Iss. 10
Open Access | Times Cited: 3
Late‐Season Influenza Vaccine Effectiveness Against Medically Attended Outpatient Illness, United States, December 2022–April 2023
Jessie R. Chung, Philip Shirk, Manjusha Gaglani, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 6
Open Access | Times Cited: 2
Influenza epidemiology and vaccine effectiveness during the 2023/2024 season in Italy: A test-negative case-control study
Alexander Domnich, Giancarlo Icardi, Donatella Panatto, et al.
International Journal of Infectious Diseases (2024) Vol. 147, pp. 107202-107202
Open Access | Times Cited: 1
Influenza Vaccine Effectiveness against Influenza A-Associated Outpatient and Emergency-Department-Attended Influenza-like Illness during the Delayed 2022–2023 Season in Beijing, China
Li Zhang, Guilan Lu, Chunna Ma, et al.
Vaccines (2024) Vol. 12, Iss. 10, pp. 1124-1124
Open Access | Times Cited: 1
Influenza Vaccine Effectiveness Against Illness and Asymptomatic Infection in 2022–2023: A Prospective Cohort Study
Elizabeth B. White, Lauren Grant, Josephine Mak, et al.
Clinical Infectious Diseases (2024)
Open Access | Times Cited: 1
Syphilis on the rise — a need for alternative therapies and vaccines
Maria Chiara Masone
Nature Reviews Urology (2024) Vol. 21, Iss. 8, pp. 457-457
Closed Access
Characteristics of medically attended influenza infection across age groups before the COVID-19 pandemic in Lebanon
Amani Haddara, Zeina Houry, Nada Kara Zahreddine, et al.
Journal of Infection and Public Health (2024) Vol. 17, Iss. 9, pp. 102521-102521
Open Access
Flu-Phobia: Influenza Vaccine Hesitancy in a Rural Primary Care Setting
Samantha M Lavertue, Richard E. Terry, Rachael Muggleton
Cureus (2024)
Open Access
Comparative Effectiveness of Cell‐Based Versus Egg‐Based Influenza Vaccines in Prevention of Influenza Hospitalization During the 2022–2023 Season Among Adults 18–64 Years
Emily Rayens, Jennifer H. Ku, Lina S. Sy, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 12
Open Access
Children with severe neurological symptoms associated with SARS-CoV-2 infection during Omicron pandemic in China
Tao Zhang, Qiaofeng Zhang, Hongmei Yang, et al.
Pediatric Research (2023) Vol. 95, Iss. 4, pp. 1088-1094
Closed Access | Times Cited: 1
Page 1

Scroll to top